* Asco Immuno Oncology (updated 2024-11-28) ~ youtor.org

Asco Immuno Oncology (updated 2024-11-28)

Neoadjuvant sacituzumab govitecan for muscleinvasive bladder cancer [upl. by Sabsay]

Neoadjuvant sacituzumab govitecan for muscleinvasive bladder cancer

Duration: 0:40
53 views | 4 months ago

Sequencing immunotherapies in multiple myeloma [upl. by Meras340]

Sequencing immunotherapies in multiple myeloma

Duration: 3:11
115 views | 4 months ago

Sequencing and treatment strategies in advanced urothelial carcinoma [upl. by Wernher]

Sequencing and treatment strategies in advanced urothelial carcinoma

Duration: 1:26
46 views | 4 months ago

Development of SX682 and targeting CXCR1 and CXCR2 in melanoma [upl. by Fuld330]

Development of SX682 and targeting CXCR1 and CXCR2 in melanoma

Duration: 1:01
34 views | 5 months ago

Liquid biopsy to diagnose CNS lymphoma and monitor treatment response [upl. by Attenahs]

Liquid biopsy to diagnose CNS lymphoma and monitor treatment response

Duration: 4:20
164 views | 4 months ago

Development of AdAPT001 a novel TGFβtrapenhanced oncolytic virus [upl. by Xenia]

Development of AdAPT001 a novel TGFβtrapenhanced oncolytic virus

Duration: 0:38
42 views | 5 months ago

Updates in kidney cancer to look out for at ASCO 2024 [upl. by Oiredised912]

Updates in kidney cancer to look out for at ASCO 2024

Duration: 0:56
88 views | 5 months ago

The potential of immunotherapies in the myeloma treatment landscape [upl. by Gurney248]

The potential of immunotherapies in the myeloma treatment landscape

Duration: 0:36
152 views | 3 months ago

Next generation CAR Tcell therapies for solid tumors [upl. by Charley]

Next generation CAR Tcell therapies for solid tumors

Duration: 0:39
1 views | 4 months ago

Talquetamab treatment in patients with RR myeloma with prior exposure to Tcelldirected therapies [upl. by Lily]

Talquetamab treatment in patients with RR myeloma with prior exposure to Tcelldirected therapies

Duration: 0:42
49 views | 10 months ago

Exploring novel SCCA treatments CD4 vaccine checkpoint inhibitor [upl. by Vitia216]

Exploring novel SCCA treatments CD4 vaccine checkpoint inhibitor

Duration: 0:31
409 views | 10 months ago

ASCO GU 2024 immunotherapy highlights in kidney cancer [upl. by Opiak623]

ASCO GU 2024 immunotherapy highlights in kidney cancer

Duration: 1:13
64 views | 3 Jul 2023

Overcoming immunooncology resistance in lung cancer [upl. by Barram]

Overcoming immunooncology resistance in lung cancer

Duration: 0:46
49 views | 5 months ago

Infliximab versus vedolizumab for ICI colitis a randomized clinical trial overview [upl. by Akeme]

Infliximab versus vedolizumab for ICI colitis a randomized clinical trial overview

Duration: 1:38
14 views | 5 months ago

Assessing the link between the gut microbiome and response rates in mesothelioma [upl. by Almeda]

Assessing the link between the gut microbiome and response rates in mesothelioma

Duration: 1:06
171 views | 4 months ago

A pilot study of axicel in primary and secondary CNS lymphomas [upl. by Frentz626]

A pilot study of axicel in primary and secondary CNS lymphomas

Duration: 4:14
3.1K views | 15 Nov 2023

ImmunoOncology Symposium Part 1 [upl. by Gnilyarg]

ImmunoOncology Symposium Part 1

Duration: 2:16:45
41 views | 5 months ago

Evaluating JZP898 an IFNα and pembrolizumab in advanced solid tumors [upl. by Yesnek]

Evaluating JZP898 an IFNα and pembrolizumab in advanced solid tumors

Duration: 0:52
182 views | 4 months ago

Advancements in bispecific and trispecific antibodies for the treatment of lymphoma [upl. by Nordek410]

Advancements in bispecific and trispecific antibodies for the treatment of lymphoma

Duration: 2:39
2 views | 4 months ago

Advancements in quadruplet regimens for the treatment of multiple myeloma [upl. by Tolkan]

Advancements in quadruplet regimens for the treatment of multiple myeloma

Duration: 2:17
261 views | 10 months ago

REGONEXT 2L regorafenib in patients with unresectable HCC who have progressed on atezobev [upl. by Nnayar]

REGONEXT 2L regorafenib in patients with unresectable HCC who have progressed on atezobev

Duration: 1:15
63 views | 5 months ago

CheckMate 901 nivolumab with gemcitabinecisplatin in urothelial carcinoma [upl. by Eerolam402]

CheckMate 901 nivolumab with gemcitabinecisplatin in urothelial carcinoma

Duration: 2:06
61 views | 4 months ago

Ciltacel versus SoC in functionally highrisk myeloma with one prior therapy [upl. by Acimaj]

Ciltacel versus SoC in functionally highrisk myeloma with one prior therapy

Duration: 2:21
71 views | 5 months ago

BCMAtargeted CART therapy is tolerable in multiple myeloma with CNS involvement [upl. by Anoit]

BCMAtargeted CART therapy is tolerable in multiple myeloma with CNS involvement

Duration: 1:27
74 views | 5 months ago

Phase III trial of AdAPT001 an oncolytic virus and a checkpoint inhibitor in solid tumors [upl. by Ahsila]

Phase III trial of AdAPT001 an oncolytic virus and a checkpoint inhibitor in solid tumors

Duration: 0:48
414 views | 5 months ago

JNJ6420 an antihK2 antibody–based targeted radiotherapy in mCRPC [upl. by Steck]

JNJ6420 an antihK2 antibody–based targeted radiotherapy in mCRPC

Duration: 3:58
68 views | 5 months ago

Highlights in skin cancer at ASCO 2024 [upl. by Rianna987]

Highlights in skin cancer at ASCO 2024

Duration: 2:41
74 views | 5 months ago

IMmotion010 KIM1 as a biomarker in patients with RCC receiving atezolizumab [upl. by Joachima313]

IMmotion010 KIM1 as a biomarker in patients with RCC receiving atezolizumab

Duration: 0:57
47 views | 4 months ago

The emerging role of ctDNA as a predicative marker in dMMRMSIH colorectal cancer [upl. by Esele]

The emerging role of ctDNA as a predicative marker in dMMRMSIH colorectal cancer

Duration: 1:57
|

Sequencing of BCMAdirected therapies for multiple myeloma [upl. by Ayit364]

Sequencing of BCMAdirected therapies for multiple myeloma

Duration: 1:21
|

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024